2
Clinical Trials associated with INV-101(Innovo Therapeutics)A First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of INV-101 Administered Orally to Healthy Adult Subjects
The goal of this study is to evaluate the safety and tolerability of single ascending oral doses of INV-101 in healthy adult subjects.
A Single Center, Phase I, Double-Blind, Placebo-Controlled Evaluation of the Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female Subjects
Single center, randomized, double-blinded, placebo-controlled, single ascending-dose study for the evaluation of the safety, tolerability, and PK following single oral doses of INV-101.
100 Clinical Results associated with INV-101(Innovo Therapeutics)
100 Translational Medicine associated with INV-101(Innovo Therapeutics)
100 Patents (Medical) associated with INV-101(Innovo Therapeutics)
100 Deals associated with INV-101(Innovo Therapeutics)